Gujarat Kidney IPO Opens Today: Check price band, lot size, key dates and other details before applying

Gujarat-based healthcare company Gujarat Kidney and Super Speciality has opened its initial public offering (IPO) for public subscription today, December 22, 2025.

The Rs 251-crore IPO comes after the company successfully raised over Rs 100 crore from anchor investors. Here are all the key details investors need to know.

Gujarat Kidney IPO: Key Dates

Add Zee Business as a Preferred Source

The Gujarat Kidney IPO opens for subscription on December 22, 2025, and will close on December 24, 2025.

The basis of allotment is expected to be finalised on December 26, 2025.

The company's shares are expected to be listed on the BSE and NSE on December 30, 2025, pending regulatory approvals.

Gujarat Kidney IPO: Price Band and Lot Size

The company has fixed a price band of Rs 108 to Rs 114 per equity share for the IPO. The lot size is 128 shares.

Retail investors will need to invest a minimum of Rs 14,592, calculated at the upper end of the price band (Rs 114 × 128 shares).

Gujarat Kidney IPO Size and Issue Details

The Gujarat Kidney IPO is a pure fresh issue of up to 2.2 crore equity shares, amounting to Rs 250.8 crore at the upper price band.

There is no offer-for-sale (OFS) component in the issue.

The IPO is being managed by Nirbhay Capital Services, which is the sole book-running lead manager.

Anchor Investor Interest

Ahead of the IPO opening, Gujarat Kidney and Super Speciality raised Rs 100.01 crore from anchor investors.

A total of 10 anchor investors participated, including Venus Investments, Khandelwal Finance Pvt Ltd, Nexus Global Opportunities Fund, and Sunrise Investment Opportunities Fund.

The company allocated 87.73 lakh equity shares at Rs 114 per share to anchor investors.

Use of IPO Proceeds

The company plans to use a part of the funds for the proposed acquisition of Parekhs Hospital in Ahmedabad and for making part-payment towards the already acquired Ashwini Medical Centre.

The company also intends to establish a new hospital in Vadodara and acquire robotics equipment for the facility. In addition, the IPO proceeds will be used for debt repayment, funding future inorganic growth opportunities, and meeting general corporate purposes.

About the Company and Financials

Gujarat Kidney and Super Speciality operates seven mid-sized multi-speciality hospitals across Gujarat, with a total capacity of 490 beds. The company focuses on secondary and tertiary care services.

For FY25, the company reported revenue of Rs 40.24 crore and a net profit of Rs 9.5 crore, highlighting steady financial performance.